WallStreetZenWallStreetZen

NASDAQ: RAPP
Rapport Therapeutics Inc Stock Ownership - Who owns Rapport Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Rapport Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Cheryl GaultCOO2026-09-302,075$33.76
$70.04kSell
Cheryl GaultCOO2026-09-307,925$33.04
$261.81kSell
Abraham CeesayCEO2026-09-231,952$39.05
$76.23kSell
Abraham CeesayCEO2026-09-23215$39.86
$8.57kSell
Abraham CeesayCEO2026-09-2343$41.05
$1.77kSell
Abraham CeesayCEO2026-09-087,141$45.56
$325.31kSell
Abraham CeesayCEO2026-09-081,069$46.02
$49.19kSell
Krishnaswamy YeleswaramCXO2026-08-2520,799$50.31
$1.05MSell
Krishnaswamy YeleswaramCXO2026-08-2516,201$51.06
$827.19kSell
Abraham CeesayCEO2026-08-2518,921$49.57
$937.95kSell

1 of 8

RAPP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RAPP insiders and whales buy or sell their stock.

RAPP Shareholders

What type of owners hold Rapport Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Third Rock Ventures V LP15.11%7,249,743$238.01MInsider
Arch Venture Partners XII LLC7.77%3,728,738$122.41MInsider
James Healy4.16%1,995,594$65.52MInsider
Abraham Ceesay1.38%661,683$21.72MInsider
Steven M. Paul1.08%519,308$17.05MInsider
David Bredt0.82%393,075$12.90MInsider
Bradley S. Galer0.41%197,426$6.48MInsider
Krishnaswamy Yeleswaram0.41%195,862$6.43MInsider
Cheryl Gault0.29%139,914$4.59MInsider
Reid M. Huber0.04%20,400$669.73kInsider

1 of 3

RAPP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RAPP0.11%31.52%Net SellingNet Selling
IMCR0.10%4.27%Net Selling
OCUL0.09%17.33%Net SellingNet Selling
SNDX0.12%10.40%Net SellingNet Buying
GHRS0.08%21.86%
View Top Biotech Stocks

Rapport Therapeutics Stock Ownership FAQ

Who owns Rapport Therapeutics?

Rapport Therapeutics (NASDAQ: RAPP) is owned by 0.11% institutional shareholders, 31.52% Rapport Therapeutics insiders, and 68.38% retail investors. Third Rock Ventures V LP is the largest individual Rapport Therapeutics shareholder, owning 7.25M shares representing 15.11% of the company. Third Rock Ventures V LP's Rapport Therapeutics shares are currently valued at $233.22M.

If you're new to stock investing, here's how to buy Rapport Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.